157 related articles for article (PubMed ID: 26540241)
1. Bisphosphonate-Induced Orbital Inflammation: A Case Series and Review.
Pirbhai A; Rajak SN; Goold LA; Cunneen TS; Wilcsek G; Martin P; Leibovitch I; Selva D
Orbit; 2015; 34(6):331-5. PubMed ID: 26540241
[TBL] [Abstract][Full Text] [Related]
2. A Case Series and Review of Bisphosphonate-associated Orbital Inflammation.
Lefebvre DR; Mandeville JT; Yonekawa Y; Arroyo JG; Torun N; Freitag SK
Ocul Immunol Inflamm; 2016; 24(2):134-9. PubMed ID: 25153041
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate-induced orbital inflammation.
Mbekeani JN; Slamovits TL
J Neuroophthalmol; 2010 Jun; 30(2):205-6; author reply 206. PubMed ID: 20523198
[No Abstract] [Full Text] [Related]
4. Orbital inflammation after zoledronate infusion: an emerging complication.
Rahimy E; Law SK
Can J Ophthalmol; 2013 Feb; 48(1):e11-2. PubMed ID: 23419305
[No Abstract] [Full Text] [Related]
5. Zolendronate associated inflammatory orbital disease.
Yeo J; Jafer AK
N Z Med J; 2010 Sep; 123(1323):50-2. PubMed ID: 20930911
[TBL] [Abstract][Full Text] [Related]
6. Zoledronic acid infusion and orbital inflammatory disease.
Sharma NS; Ooi JL; Masselos K; Hooper MJ; Francis IC
N Engl J Med; 2008 Sep; 359(13):1410-1. PubMed ID: 18815406
[No Abstract] [Full Text] [Related]
7. Bisphosphonate-associated orbital inflammation--a case report and review.
Peterson JD; Bedrossian EH
Orbit; 2012 Apr; 31(2):119-23. PubMed ID: 22489855
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonate-induced orbital inflammation: more common than once thought?
Chehade LK; Curragh D; Selva D
Osteoporos Int; 2019 May; 30(5):1117-1120. PubMed ID: 30675627
[TBL] [Abstract][Full Text] [Related]
9. [Bisphosphonate-induced ocular and orbital inflammation].
Jakobsen TS; Funding M
Ugeskr Laeger; 2022 Jul; 184(28):. PubMed ID: 35959811
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonate-associated orbital inflammatory disease and uveitis anterior--a case report and review.
Böni C; Kordic H; Chaloupka K
Klin Monbl Augenheilkd; 2013 Apr; 230(4):367-9. PubMed ID: 23629782
[TBL] [Abstract][Full Text] [Related]
11. Nitrogen bisphosphonate-induced orbital inflammatory disease: gamma delta T cells--a report and review of 2 cases.
Vora MM; Rodgers IR; Uretsky S
Ophthalmic Plast Reconstr Surg; 2014; 30(4):e84-5. PubMed ID: 24814269
[TBL] [Abstract][Full Text] [Related]
12. Aminobisphosphonate-associated orbital and ocular inflammatory disease.
Keren S; Leibovitch I; Ben Cnaan R; Neudorfer M; Fogel O; Greenman Y; Shulman S; Zur D; Habot-Wilner Z
Acta Ophthalmol; 2019 Aug; 97(5):e792-e799. PubMed ID: 30816018
[TBL] [Abstract][Full Text] [Related]
13. Ocular Side Effects of Bisphosphonates: A Review of Literature.
Chartrand NA; Lau CK; Parsons MT; Handlon JJ; Ronquillo YC; Hoopes PC; Moshirfar M
J Ocul Pharmacol Ther; 2023; 39(1):3-16. PubMed ID: 36409537
[TBL] [Abstract][Full Text] [Related]
14. Orbital inflammatory disease in a patient treated with zoledronate.
Kaur H; Uy C; Kelly J; Moses AM
Endocr Pract; 2011; 17(4):e101-3. PubMed ID: 21803720
[TBL] [Abstract][Full Text] [Related]
15. Diffuse ocular and orbital inflammation after zoledronate infusion-case report and review of the literature.
Umunakwe OC; Herren D; Kim SJ; Kohanim S
Digit J Ophthalmol; 2017; 23(4):18-21. PubMed ID: 29403337
[TBL] [Abstract][Full Text] [Related]
16. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
[TBL] [Abstract][Full Text] [Related]
17. The incidence of acute anterior uveitis after intravenous zoledronate.
Patel DV; Horne A; House M; Reid IR; McGhee CN
Ophthalmology; 2013 Apr; 120(4):773-6. PubMed ID: 23290982
[TBL] [Abstract][Full Text] [Related]
18. [Inflammation of the jaws during treatment with bisphosphonates].
Bartl R
Dtsch Med Wochenschr; 2011 Oct; 136(41):2109-10. PubMed ID: 21971888
[No Abstract] [Full Text] [Related]
19. Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals.
Magopoulos C; Karakinaris G; Telioudis Z; Vahtsevanos K; Dimitrakopoulos I; Antoniadis K; Delaroudis S
Am J Otolaryngol; 2007; 28(3):158-63. PubMed ID: 17499130
[TBL] [Abstract][Full Text] [Related]
20. Orbital myositis induced by alendronate: A case report.
Lefeuvre L; Caruso A; Biver E; Fayolle D
Eur J Neurol; 2023 Jun; 30(6):1828-1830. PubMed ID: 36880870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
